Boris A Stuck1, Madeline J L Ravesloot2, Till Eschenhagen3, H C W de Vet4, J Ulrich Sommer3. 1. Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Marburg, Philipps-Universität Marburg, Germany. 2. Department of Otorhinolaryngology, Head and Neck Surgery, OLVG, Amsterdam, The Netherlands. Electronic address: m.j.l.ravesloot@olvg.nl. 3. Department of Otorhinolaryngology Head and Neck Surgery, Medical Faculty Mannheim, University of Heidelberg, Germany. 4. Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, VU University Medical Center, Amsterdam, The Netherlands.
Abstract
BACKGROUND: The most commonly performed surgical procedure for obstructive sleep apnea (OSA) is uvulopalatopharyngoplasty with or without tonsillectomy (UPPP ± TE). However, there is currently no review solely focusing on clinically relevant effects of standard UPPP technique with or without tonsillectomy as a monotherapy in patients with OSA. METHODS: A systematic review and meta-analysis were performed to assess the effects of isolated UPPP ± TE in patients with OSA. Studies of any design referring to adult patients with obstructive sleep apnea diagnosed via polysomnography or comparable objective measures were considered, in which isolated "standard" UPPP ± TE was performed. RESULTS: Forty-eight studies were included for the qualitative analysis. All but one study demonstrated a reduction in the frequency of respiratory events and success/response rates ranged from 35 to 95.2%. In the six studies that reported pre- and postoperative mean scores of the Epworth Sleepiness Scale (ESS), a reduction in sleepiness scores was demonstrated. Data addressing the effect of UPPP ± TE in comparison to no treatment or control were available from two randomized controlled trials (RCT). When pooling the data, UPPP ± TE was significantly more effective in reducing the apnea-hypopnea index (AHI) and Epworth Sleepiness Scale (ESS) (large effect): an AHI mean difference (MD) of -18.59 (95% CI -34.14, -3.04) and an ESS MD of -5.37 (95% CI -7,03, -3.72). Data addressing effect of UPPP ± TE in comparison to baseline was available from three RCT. When pooling the data, the AHI was reduced from a mean 35.4 to 17.9 (49.5% reduction); a MD of -20.41, 95% CI -32.78, -8.04 (-1.80, -1.15) (large effect). Various additional beneficial effects of UPPP ± TE were demonstrated including improvement in sexual function, ventricular function, sleep stages, serum lipid, depressive disorder and driving performance. CONCLUSION: UPPP ± TE reduces respiratory events and daytime sleepiness in adult patients with OSA and UPPP ± TE is superior to non-treated controls in this regard. Further research is needed to establish the long-term benefit, the impact on cardiovascular morbidity and the role of UPPP ± TE in the variety of available treatment options for OSA.
BACKGROUND: The most commonly performed surgical procedure for obstructive sleep apnea (OSA) is uvulopalatopharyngoplasty with or without tonsillectomy (UPPP ± TE). However, there is currently no review solely focusing on clinically relevant effects of standard UPPP technique with or without tonsillectomy as a monotherapy in patients with OSA. METHODS: A systematic review and meta-analysis were performed to assess the effects of isolated UPPP ± TE in patients with OSA. Studies of any design referring to adult patients with obstructive sleep apnea diagnosed via polysomnography or comparable objective measures were considered, in which isolated "standard" UPPP ± TE was performed. RESULTS: Forty-eight studies were included for the qualitative analysis. All but one study demonstrated a reduction in the frequency of respiratory events and success/response rates ranged from 35 to 95.2%. In the six studies that reported pre- and postoperative mean scores of the Epworth Sleepiness Scale (ESS), a reduction in sleepiness scores was demonstrated. Data addressing the effect of UPPP ± TE in comparison to no treatment or control were available from two randomized controlled trials (RCT). When pooling the data, UPPP ± TE was significantly more effective in reducing the apnea-hypopnea index (AHI) and Epworth Sleepiness Scale (ESS) (large effect): an AHI mean difference (MD) of -18.59 (95% CI -34.14, -3.04) and an ESS MD of -5.37 (95% CI -7,03, -3.72). Data addressing effect of UPPP ± TE in comparison to baseline was available from three RCT. When pooling the data, the AHI was reduced from a mean 35.4 to 17.9 (49.5% reduction); a MD of -20.41, 95% CI -32.78, -8.04 (-1.80, -1.15) (large effect). Various additional beneficial effects of UPPP ± TE were demonstrated including improvement in sexual function, ventricular function, sleep stages, serum lipid, depressive disorder and driving performance. CONCLUSION: UPPP ± TE reduces respiratory events and daytime sleepiness in adult patients with OSA and UPPP ± TE is superior to non-treated controls in this regard. Further research is needed to establish the long-term benefit, the impact on cardiovascular morbidity and the role of UPPP ± TE in the variety of available treatment options for OSA.
Authors: Pien F N Bosschieter; Nico de Vries; Reena Mehra; Shalini Manchanda; Tapan A Padhya; Olivier M Vanderveken; M J L Ravesloot Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324
Authors: Shazia M Jamil; Robert L Owens; Melissa C Lipford; Shirin Shafazand; Robert M Marron; Maria Elena Vega Sanchez; Michael T Lam; Bernie Y Sunwoo; Christopher Schmickl; Jeremy E Orr; Snigdha Sharma; Abdulghani Sankari; Sogol Javaheri; Suzanne Bertisch; Kara Dupuy-McCauley; Bhanu Kolla; Ikuyo Imayama; Bharati Prasad; Elizabeth Guzman; Margaret M Hayes; Tisha Wang Journal: ATS Sch Date: 2020-12-30
Authors: Ai-Ming Wong; Shane A Landry; Simon A Joosten; Luke D J Thomson; Anthony Turton; Jeremy Stonehouse; Darren R Mansfield; Glen Burgess; Andrew Hays; Scott A Sands; Christopher Andara; Caroline J Beatty; Garun S Hamilton; Bradley A Edwards Journal: Respirology Date: 2022-05-21 Impact factor: 6.175
Authors: Jeremy R Tietjens; David Claman; Eric J Kezirian; Teresa De Marco; Armen Mirzayan; Bijan Sadroonri; Andrew N Goldberg; Carlin Long; Edward P Gerstenfeld; Yerem Yeghiazarians Journal: J Am Heart Assoc Date: 2019-01-08 Impact factor: 5.501